Evidence map›Paper›PMID 24963152›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.

Jian Yan, Stephen D Ginsberg, Brian Powers, Melissa J Alldred, Arthur Saltzman, Barbara J Strupp, Marie A Caudill

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jian YanDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA;
Stephen D GinsbergCenter for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA; and Department of Psychiatry and Department of Physiology and Neuroscience, New York University Langone Medical Center, New York, New York, USA.
Brian PowersDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA;
Melissa J AlldredCenter for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA; and Department of Psychiatry and.
Arthur SaltzmanCenter for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA; and.
Barbara J StruppDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA;
Marie A CaudillDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA; mac379@cornell.edu.

Funding

Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal functionP01AG017617 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI NIXON, RALPH A. · 2000 to 2021
$40.0M
TAU, AB, SYNUCLEIN AND NITRATIVE/OXIDATIVE DAMAGE IN MCIP01AG014449 · NIA · UNIVERSITY OF PITTSBURGH · PI IKONOMOVIC, MILOS D · 1997 to 2024
$39.7M
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjectsR01AG043375 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GINSBERG, STEPHEN D, MUFSON, ELLIOTT JAY · 2013 to 2017
$3.6M
Perinatal choline therapy in a mouse model of Down Syndrome & Alzheimer's DiseaseR01HD057564 · NICHD · CORNELL UNIVERSITY · PI STRUPP, BARBARA J · 2008 to 2012
$2.9M
NIA NIH HHS AG014449NIA NIH HHS AG017617NIA NIH HHS AG043375NIA NIH HHS P01 AG014449NIA NIH HHS P01 AG017617NIA NIH HHS R01 AG043375NICHD NIH HHS HD057564NICHD NIH HHS R01 HD057564
6 · The paper itself

Abstract

Maternal choline supplementation (MCS) induces lifelong cognitive benefits in the Ts65Dn mouse, a trisomic mouse model of Down syndrome and Alzheimer's disease. To gain insight into the mechanisms underlying these beneficial effects, we conducted a study to test the hypothesis that MCS alters choline metabolism in adult Ts65Dn offspring. Deuterium-labeled methyl-d9-choline was administered to adult Ts65Dn and disomic (2N) female littermates born to choline-unsupplemented or choline-supplemented Ts65Dn dams. Enrichment of d9-choline metabolites (derived from intact choline) and d3 + d6-choline metabolites [produced when choline-derived methyl groups are used by phosphatidylethanolamine N-methyltransferase (PEMT)] was measured in harvested tissues. Adult offspring (both Ts65Dn and 2N) of choline-supplemented (vs. choline-unsupplemented) dams exhibited 60% greater (P≤0.007) activity of hepatic PEMT, which functions in de novo choline synthesis and produces phosphatidylcholine (PC) enriched in docosahexaenoic acid. Higher (P<0.001) enrichment of PEMT-derived d3 and d6 metabolites was detected in liver, plasma, and brain in both genotypes but to a greater extent in the Ts65Dn adult offspring. MCS also yielded higher (P<0.05) d9 metabolite enrichments in liver, plasma, and brain. These data demonstrate that MCS exerts lasting effects on offspring choline metabolism, including up-regulation of the hepatic PEMT pathway and enhanced provision of choline and PEMT-PC to the brain.

Indexed as

Prenatal Exposure Delayed EffectsAnimalsCholineDietary SupplementsDocosahexaenoic AcidsDown SyndromeFemaleLipid MetabolismMiceMice, Inbred C57BLPhosphatidylcholinesPhosphatidylethanolamine N-MethyltransferasePregnancyTissue DistributionCholineDocosahexaenoic AcidsPEMT protein, mousePhosphatidylcholinesPhosphatidylethanolamine N-MethyltransferaseAlzheimer's diseasedocosahexaenoic acidDown syndromefetal programmingphosphatidylcholine

Identifiers

PMID24963152
PMCPMC4202107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.